111 (NASDAQ:YI) Director Jian David Sun Sells 111,100 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 111,100 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00. Following the completion of the transaction, the director owned 472,011 shares in the company, valued at $108,562.53. The trade was a 19.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Performance

NASDAQ YI opened at $4.89 on Friday. 111, Inc. Sponsored ADR has a one year low of $2.48 and a one year high of $11.17. The company’s 50 day moving average price is $5.92 and its 200 day moving average price is $5.64. The firm has a market capitalization of $42.98 million, a price-to-earnings ratio of -3.49 and a beta of 0.60.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, 111 presently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.